---
title: "ASHCROFT PHARMA LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/ccbb1cc6-7a7a-525d-9db9-c0f32dc91fa5
json: https://whiteintel.dev/api/public/dossier/ccbb1cc6-7a7a-525d-9db9-c0f32dc91fa5
identifier: oo:GB-COH-09428993
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# ASHCROFT PHARMA LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-09428993`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/ccbb1cc6-7a7a-525d-9db9-c0f32dc91fa5  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/ccbb1cc6-7a7a-525d-9db9-c0f32dc91fa5  

## Cross-source identity

The same real-world entity, resolved across sources:

- **ASHCROFT PHARMA LIMITED** — GLEIF · `lei:894500ILMFINF4ZVKE86` — https://whiteintel.dev/entity/4545dd3b-522d-5e55-96e0-05a67e942dca

## Ownership & control

### Owners / controllers

- **Mr Shoaib Jamil** (beneficial owner) — 50% — https://whiteintel.dev/entity/f5c37c7b-c1be-55dc-9627-b3bfa95e589d
- **Mr Suhail Jamil** (beneficial owner) — 62.5% — https://whiteintel.dev/entity/635608f1-da72-4399-b6fa-06eeba4f0e16
- **Mr Shoaib Jamil** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/7beccd89-2c57-4b78-b9c2-58c8b587669d

### Holdings / subsidiaries

- **ASHCROFT4PETS LTD** (beneficial owner) — 50% — https://whiteintel.dev/entity/c62619a8-8e4e-5345-aa6e-645ee72c4f90
- **PHARM4PETS LIMITED** (beneficial owner) — 50% — https://whiteintel.dev/entity/8f75f7b9-fca4-5ceb-af9a-08aa32bc5fee
- **ASHCROFT4PETS LTD** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/c62619a8-8e4e-5345-aa6e-645ee72c4f90
- **PHARM4PETS LIMITED** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/8f75f7b9-fca4-5ceb-af9a-08aa32bc5fee

### UBO chain (walk to the ultimate owner)

A **3-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `09428993`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2015-02-09
- **Registered office:** 162 Clayton Road, Bradford, BD7 2RD, England
- **SIC:** 74909, 86900

### Officers

- JAMIL, Suhail — director · British · appointed 2021-06-01
- JAMIL, Shoaib — director · British · appointed 2015-02-09 · resigned 2025-06-01
- KHAN, Sadia Naz — director · British · appointed 2015-02-09 · resigned 2019-09-30

### Beneficial owners (Persons with Significant Control)

- Mr Suhail Jamil — 50–75% shares · individual PSC · England — since 2025-06-01
- Mr Shoaib Jamil — 25–50% shares · individual PSC · England — ceased 2025-06-01

## Provenance

- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/09428993
- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/09428993

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **ASHCROFT PHARMA LIMITED**. Human view: https://whiteintel.dev/entity/ccbb1cc6-7a7a-525d-9db9-c0f32dc91fa5 · Structured JSON: https://whiteintel.dev/api/public/dossier/ccbb1cc6-7a7a-525d-9db9-c0f32dc91fa5._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._